Cowan Elvia

SVP, Finance & CAOVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Mar 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$105K
Net Open-Market Flow
-$105K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2026Sell(S)405$56.26$23K29K
Mar 17, 2026Sell(S)1K$55.39$82K29K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001960048-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly: